BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30500898)

  • 1. Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study.
    Denisuik AJ; Garbutt LA; Golden AR; Adam HJ; Baxter M; Nichol KA; Lagacé-Wiens P; Walkty AJ; Karlowsky JA; Hoban DJ; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2019 Mar; 74(3):645-653. PubMed ID: 30500898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
    Zhanel GG; DeCorby M; Laing N; Weshnoweski B; Vashisht R; Tailor F; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; McCracken M; Mulvey MR; Johnson J; ; Hoban DJ
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1430-7. PubMed ID: 18285482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
    Zhang Z; Chen M; Yu Y; Pan S; Liu Y
    Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 study.
    Zhanel GG; Adam HJ; Low DE; Blondeau J; Decorby M; Karlowsky JA; Weshnoweski B; Vashisht R; Wierzbowski A; Hoban DJ;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):291-306. PubMed ID: 21353957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
    Vega S; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.
    Adam HJ; DeCorby M; Rennie R; Karlowsky JA; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):307-13. PubMed ID: 21353958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
    Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016.
    Dowzicky MJ; Chmelařová E
    J Glob Antimicrob Resist; 2019 Jun; 17():44-52. PubMed ID: 30445209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).
    Zhanel GG; DeCorby M; Adam H; Mulvey MR; McCracken M; Lagacé-Wiens P; Nichol KA; Wierzbowski A; Baudry PJ; Tailor F; Karlowsky JA; Walkty A; Schweizer F; Johnson J; ; Hoban DJ
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4684-93. PubMed ID: 20805395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study.
    Zhanel GG; Adam HJ; Baxter MR; Fuller J; Nichol KA; Denisuik AJ; Lagacé-Wiens PR; Walkty A; Karlowsky JA; Schweizer F; Hoban DJ;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i7-22. PubMed ID: 23587781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of nosocomial pneumonia in infants after cardiac surgery.
    Tan L; Sun X; Zhu X; Zhang Z; Li J; Shu Q
    Chest; 2004 Feb; 125(2):410-7. PubMed ID: 14769717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R; Noriega ER; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study.
    Zhanel GG; Adam HJ; Baxter MR; Fuller J; Nichol KA; Denisuik AJ; Golden AR; Hink R; Lagacé-Wiens PRS; Walkty A; Mulvey MR; Schweizer F; Bay D; Hoban DJ; Karlowsky JA;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv5-iv21. PubMed ID: 31505641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.
    Balode A; Punda-Polić V; Dowzicky MJ
    Int J Antimicrob Agents; 2013 Jun; 41(6):527-35. PubMed ID: 23590898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM; Jones RN; Sader HS; Fritsche TR
    Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.
    Uc-Cachón AH; Gracida-Osorno C; Luna-Chi IG; Jiménez-Guillermo JG; Molina-Salinas GM
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31540314
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The composition and antimicrobial resistance of isolates from lower respiratory tract and blood in hospitalized patients in respiratory ward: a multicenter national study in China].
    Tang X; Zhuo C; Xu YC; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Apr; 41(4):281-287. PubMed ID: 29690684
    [No Abstract]   [Full Text] [Related]  

  • 20. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.